NCT05962697

Brief Summary

Stroke is the leading cause of adult-onset disability, and affects 15,000 Veterans each year. Successful rehabilitation and recovery following a stroke requires therapy including repetitive task training. However, repetitive task training can be draining for both the clinician and the patient as it requires the participant to complete many repetitions of the same task and those repetitions can be difficult to accomplish with appropriate technique. Robot-mediated repetitive task training has the potential to facilitate the clinical delivery of proven rehabilitation programs to Veterans in need and recently a new exoskeleton has been developed, called Harmony, which can deliver bimanual 3D arm therapy. The investigators propose to develop and test two novel controllers', synergy avoidance and task assistance, that use promising neurological basis for training to facilitate repetitive task training while ensuring correct movement patterns in acute and sub-acute stage stroke patients. This has the potential to improve Veterans' activities of daily living and quality of life.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

August 3, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2025

Completed
Last Updated

August 20, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

July 10, 2023

Last Update Submit

August 15, 2025

Conditions

Keywords

StrokeExoskeletonupper extremityrobotrehabilitationjoint synergycontrollerfeasibility

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline Fugl-Meyer Upper Extremity (FM-UE) at 3 weeks

    Clinical measure of upper extremity function Range 0 to 66 - 0 is impaired, 66 is unimpaired

    3 weeks

  • Change from Baseline Action Research Arm Test (ARAT) at 3 weeks

    Clinical measure of upper extremity function Range 0 to 57 0 is impaired, 57 is unimpaired

    3 weeks

Study Arms (2)

SA controller

EXPERIMENTAL

Synergy assistance controller

Other: SA controllerOther: TA controller

early testing

OTHER

up to 5 participants testing the SA controller in one visit

Other: SA controller early testing

Interventions

Novel controller to be tested

Also known as: Synergy assistance
SA controller

original controller to be tested

Also known as: Task assistance
SA controller

Novel controller to be tested early testing

Also known as: Synergy assistance early testing
early testing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • over the age of 18 years,
  • have a Fugl-Meyer Upper Extremity score of 29-42 for moderately impaired (aim 1) or 0-28 for severely impaired (aim 1 and 2),
  • have body dimensions within the limits of the Harmony system
  • suffered a stroke within the past 1-6 months (aim 1) or 1 week (aim 2)

You may not qualify if:

  • recurrent stroke,
  • unstable cardiovascular, orthopedic, or neurological conditions,
  • a history of seizure,
  • significant communication deficits,
  • severe upper-limb joint pain or limitations that would restrict their ability to complete the protocols,
  • inadequate cognitive or language function to consent or to participate, and (7) no phone number or stable mailing address.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, 98108-1532, United States

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Brittney C Muir, PhD

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2023

First Posted

July 27, 2023

Study Start

August 3, 2024

Primary Completion

July 1, 2025

Study Completion

August 12, 2025

Last Updated

August 20, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations